Companies & Markets Show 30 September 2016 episode artwork

EPISODE · Sep 29, 2016 · 43 MIN

Companies & Markets Show 30 September 2016

from Investors' Chronicle

Good drugs and bad banks: In our 100th episode, editor John Hughman and the companies team talk about the bubbling drug discovery pipeline and the ongoing troubles of Europe's banking industryInvestors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Sep 29, 2016

Embed this episode

NOW PLAYING

Companies & Markets Show 30 September 2016

0:00 43:29

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Investors' Chronicle?

This episode is 43 minutes long.

When was this Investors' Chronicle episode published?

This episode was published on September 29, 2016.

Can I download this Investors' Chronicle episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!